Poor clinical outcomes and immunoevasive contexture in CD161+CD8+ T cells barren human pancreatic cancer.
Chen Q, Yin H, Jiang Z, He T, Xie Y, Mao W, Han J, Liu S, Lou W, Wu W, Habib JR, Yu J, Liu L, Pu N.
Chen Q, et al. Among authors: pu n.
J Immunother Cancer. 2024 Mar 26;12(3):e008694. doi: 10.1136/jitc-2023-008694.
J Immunother Cancer. 2024.
PMID: 38531664
Free PMC article.